Comparison effect of melatonin and zinc in optimization of sleep disorder in cirrhotic patients
Phase 3
- Conditions
- Patients with diagnosis of cirrhosis.Unspecified cirrhosis of liverK74.60
- Registration Number
- IRCT20121021011192N18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Patients with diagnosis of cirrhosis on the basis of doing liver biopsy obtaining written informed consent
Exclusion Criteria
Patients with previous history of allergy to melatonin or zinc
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of sleep in cirrhotic patienr. Timepoint: 4 weeks after starting the treatment. Method of measurement: Pittsburg questionnaire.
- Secondary Outcome Measures
Name Time Method